We are a team of scientists dedicated to advancing medical research

by helping doctors, patients and scientists collaborate on clinical trials

Conall Arora CEO

Conall Arora oversees the CLIA and Research Lab and the CRO/ Sample Collection Division. He joined RDI in 2017 as CEO and brings vast experience in building best-in-class businesses to his role. He has been instrumental in expanding RDI’s reach by adding new physicians nationwide, opening new lab locations, as well as leading the development of RDI’s proprietary paperless trial and remote monitoring system. Conall holds degrees in pre-med and economics from Columbia University, New York and prior to RDI spent his career investing in and developing businesses across industries ranging from software start-ups to large public companies with revenues above $2.5 billion per year.

Dr. Michael Samoszuk, Chief PI, Pathologist, Lab Medical Director

Dr. Michael Samoszuk serves as RDI’s medical lab director and principal investigator and provides clinical and medical oversight over all of RDI’s studies and CLIA lab activities. He is a licensed physician and board-certified pathologist. He also serves as a medical officer for Point of Care business at Siemens Healthineers, and previously has served as the chief medical officer for Roche Diagnostics, Ortho-Clinical Diagnostics and Beckman Coulter. Before these roles, Dr. Samoszuk oversaw the Hematology/Oncology Center for Quest Diagnostics and was an associate professor of pathology at UC-Irvine. He received his medical degree from Harvard Medical school and has served as the principal investigator on numerous clinical studies and grants. He has published more than 70 peer reviewed research papers.

Dr. Elisa Romeo, Principal Investigator

Dr. Elisa Romeo serves as the Principal Investigator for RDI’s prospective collections and provides clinical and regulatory support for RDI’s clinical trials. She is a seasoned diagnostic executive with formal training as a scientist and the experience of developing, validating and launching new diagnostic products. She has served in senior Operations roles at various diagnostic companies and been critical in obtaining 510(k), EUA, and CE approval for immunological assays, cancer biomarkers, and genetic molecular assays. She also has experience in assay development within the CLIA/CAP laboratories. She holds a PhD in Human Physiology and Biochemistry from the University of Zurich, Switzerland as well as a Masters in Biology from University of Insubria, Italy.

Lara Flores, Senior Vice President of Operations

Lara leads all operations at RDI, overseeing our sample collection and CLIA lab teams. She is a diagnostic executive experienced in managing CRO clinical trial teams and both CLIA/CAP and research lab operations. Most recently, Lara managed Global Lab Operations at NeoGenomics where she restructured their project management, data management and lab operations teams to better serve pharma and biotech clients. Prior to that role, Lara managed Business Services and Clinical Operations at Beaufort, an in vitro diagnostics CRO, where she helped diagnostic sponsors design and execute their studies. Lara holds a B.S. in Biochemistry from the University of California, Los Angeles, has authored several publications, and developed and validated 80+ assays in her career as an assay validation scientist at LabCorp, Genzyme, One Lambda (Thermo Fisher), Pathway Diagnostics (Quest Diagnostics), and Amgen.

Interested in joining our team?
See current openings